Tag: absorbable hemostats market overview

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

The absorbable hemostats market has been experiencing robust growth, propelled by advancements in surgical procedures and increasing demand for effective bleeding control solutions. This sector’s expansion reflects ongoing innovations and a rising preference for materials that enhance surgical outcomes while minimizing complications. Below, we explore the market’s current status, key growth drivers, segmentation, trends, leading companies, and regional insights shaping its future.

Steady Market Expansion and Projected Growth of the Absorbable Hemostats Market

The absorbable hemostats market has seen significant growth over recent years, with its size expected to increase from $3.37 billion in 2025 to $3.63 billion in 2026, representing a compound annual growth rate (CAGR) of 7.8%. This upward trend in the historical period is largely due to a rise in neurosurgery and orthopedic surgery volumes, increased demand for intraoperative bleeding control products, wider adoption of oxidized regenerated cellulose and gelatin-based hemostats, expansion of surgical facilities, and greater clinical acceptance of absorbable biomaterial hemostats. Looking ahead, the market is projected to reach $4.96 billion by 2030, growing at a CAGR of 8.1%. Factors contributing to this future growth include the increased use of advanced thrombin and collagen-based products, a shift toward minimally invasive and reconstructive surgeries, greater investment in bioabsorbable and hybrid hemostat innovations, the rise of ambulatory surgical centers, and heightened focus on reducing surgical complications and recovery times. Key trends in the forecast period feature the development of bioengineered absorbable materials for better tissue compatibility, wider adoption of multifunctional hemostats for rapid clot stabilization and wound healing, and growing utilization of these products in complex surgeries.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18777&type=smp

Rising Number of Surgical Procedures as a Main Growth Driver in the Absorbable Hemostats Market

An important factor fueling the absorbable hemostats market is the growing volume of surgical operations worldwide. Surgical procedures, which involve physically modifying tissues or organs, are increasingly performed due to advances in medical technology, an aging global population, and the demand for improved medical treatments. Absorbable hemostats play a critical role during surgery by controlling bleeding and encouraging clot formation while being naturally absorbed by the body, thus reducing the need for further interventions and lowering postoperative complications. For example, in April 2025, the British Association of Aesthetic Plastic Surgeons reported that 25,972 surgical procedures were conducted in the UK in 2023, with women accounting for 93% of these cosmetic surgeries and men the remaining 7%. This rise in surgical activities strongly supports the ongoing expansion of the absorbable hemostats market.

Additional Factors Supporting Market Growth

Besides the increase in surgeries, ongoing advancements in surgical techniques, particularly minimally invasive and reconstructive procedures, are driving demand for sophisticated hemostatic products. Hospitals and surgical centers are investing heavily in bioabsorbable and hybrid hemostats that offer faster clotting and improved patient outcomes. The growing emphasis on reducing postoperative complications and shortening recovery time also encourages the adoption of absorbable hemostats, especially those integrating advanced collagen, gelatin, and thrombin-based formulations.

https://www.thebusinessresearchcompany.com/report/absorbable-hemostats-global-market-report

#Absorbable Hemostats Market Largest Region: Which Geography Holds The Highest Market Share?

Segment Breakdown of the Absorbable Hemostats Market

This market can be divided into several key segments:

1) By Type: Thrombin-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Gelatin-Based Hemostats, Collagen-Based Hemostats, and Other Types.

2) By Application: Neurosurgery, Orthopedic Surgery, General Surgery, Reconstructive Surgery, and Other Applications.

3) By End-User: Hospitals and Clinics, Ambulatory Surgical Centers, and Other End-Users.

Further subcategories include lyophilized and liquid thrombin-based hemostats; pre-packaged and customizable oxidized cellulose products; gelatin sponge- and foam-based hemostats; collagen pads, sheets, sponges, and powders; as well as fibrin-based, polymeric, and other innovative or hybrid formulations.

Innovative Products and Market Trends Shaping Absorbable Hemostats Industry

Leading companies in this sector are focusing on launching advanced products like absorbable hemostatic powders designed to provide rapid and effective bleeding control during surgery. These powders work by promoting quick clot formation at the injury site and are naturally absorbed once their function is complete. For example, in July 2023, Baxter International Inc., a healthcare firm based in the US, introduced PERCLOT absorbable hemostatic powder. PERCLOT granules have a unique molecular structure that rapidly absorb water to form a gelled adhesive matrix, creating a mechanical barrier that stops bleeding by encouraging the accumulation of platelets, red blood cells, and coagulation proteins such as thrombin and fibrinogen. This innovation supports clinicians in managing a wider variety of intraoperative bleeding scenarios, which is essential for reducing blood transfusions, minimizing complications, and lowering overall healthcare costs.

Key Players Driving Competition in the Absorbable Hemostats Market

Prominent organizations competing in the absorbable hemostats space include Johnson & Johnson, Medtronic Plc, Baxter International Inc., B. Braun Melsungen AG, Integra LifeSciences, Acelity, Meril Life Sciences Pvt. Ltd., Gelita AG, CryoLife Inc., Anika Therapeutics Inc., Z-Medica LLC, Cohera Medical Inc., Marine Polymer Technologies Inc., Curasan AG, Hemostasis LLC, Arch Therapeutics Inc., Cura Medical, FzioMed Inc., Guizhou Jin Jiu Biotech Co. Ltd., and Omrix Biopharmaceuticals Inc.

North America Leads Absorbable Hemostats Market With Asia-Pacific Showing Rapid Growth

In 2025, North America was the largest regional market for absorbable hemostats. The market report also covers critical regions such as Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East, and Africa. While North America holds the biggest share currently, the Asia-Pacific region is expected to witness the fastest growth in the coming years due to increasing healthcare infrastructure investments and rising surgical procedure volumes.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Forecasted Rise In Market Size Of The Absorbable Hemostats Market During The Forecast Period?

The absorbable hemostats market has experienced robust expansion over recent years. Its projected growth is from $3.37 billion in 2025 to $3.63 billion in 2026, advancing at a compound annual growth rate (CAGR) of 7.8%. This historical expansion can be linked to several factors, including a greater number of neurosurgery and orthopedic surgery procedures, an elevated need for intraoperative bleeding management solutions, the wider acceptance of oxidized regenerated cellulose and gelatin-based hemostats, the enlargement of hospital surgical facilities and operating rooms, and the enhanced clinical approval of absorbable biomaterial hemostats.

The absorbable hemostats market is projected to experience robust expansion in the coming years. This market is anticipated to reach $4.96 billion by 2030, progressing at a compound annual growth rate (CAGR) of 8.1%. This anticipated growth during the forecast period is fueled by several factors, including the increasing application of advanced thrombin and collagen-based formulations, a growing inclination towards minimally invasive and reconstructive surgical procedures, heightened investment in bioabsorbable and hybrid hemostat innovations, an expansion in the number of procedures performed at ambulatory surgical centers, and a greater emphasis on minimizing surgical complications and recovery periods. Key trends emerging within this period involve the accelerating development of bioengineered absorbable hemostat materials designed for improved tissue compatibility, the increasing integration of advanced collagen, gelatin, and thrombin-based hemostats in intricate surgical operations, a rising demand for multifunctional hemostatic solutions that aid in swift clot stabilization and wound healing, the expanding application of absorbable hemostats in both minimally invasive and reconstructive surgeries, and a heightened clinical emphasis on hemostats specifically formulated to mitigate post-operative complications and surgical bleeding risks.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18777&type=smp

Which Drivers Are Advancing The Absorbable Hemostats Market Growth?

The escalating number of surgical procedures is projected to drive the future expansion of the absorbable hemostats market. Surgical procedures involve medical operations undertaken to diagnose, treat, or manage various conditions by physically altering tissues or organs through incisions or alternative techniques. This rise in surgical procedures stems from an escalating demand for advanced medical treatments, an aging global population, and progress in surgical technology enabling more complex and minimally invasive interventions. Absorbable hemostats play a crucial role in surgical procedures by controlling bleeding and fostering clot formation, all while being gradually assimilated by the body. This attribute diminishes the necessity for subsequent interventions and reduces postoperative complications. For instance, in April 2025, data from the British Association of Aesthetic Plastic Surgeons, a professional organization based in the UK, indicated that a total of 25,972 surgical procedures were performed in 2023. Women constituted 93% of these cosmetic surgeries, with men accounting for the remaining 7% of cases. Therefore, the growing volume of surgical procedures is a key factor propelling the growth of the absorbable hemostasis market.

How Is The Absorbable Hemostats Market Distributed Across Key Segments?

The absorbable hemostats market covered in this report is segmented –

1) By Type: Thrombin-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Gelatin-Based Hemostats, Collagen-Based Hemostats, Other Types

2) By Application: Neurosurgery, Orthopedic Surgery, General Surgery, Reconstructive Surgery, Other Applications

3) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Thrombin-Based Hemostats: Lyophilized Thrombin Hemostats, Liquid Thrombin-Based Hemostats

2) By Oxidized Regenerated Cellulose-Based Hemostats: Pre-Packaged Oxidized Cellulose Hemostats, Customizable Oxidized Cellulose Products

3) By Gelatin-Based Hemostats: Gelatin Sponge-Based Hemostats, Gelatin Foam-Based Hemostats

4) By Collagen-Based Hemostats: Collagen-Based Pads or Sheets, Collagen-Based Sponges or Powder

5) By Other Types: Fibrin-Based Hemostats, Polymeric-Based Hemostats, Other Innovative Or Hybrid Formulations

Which Trends Are Guiding The Development Of The Absorbable Hemostats Market?

Major companies in the absorbable hemostats market are concentrating on creating sophisticated solutions, such as absorbable hemostatic powder, to ensure swift and efficient bleeding management during surgical procedures. This medical product is designed to manage hemorrhage by facilitating rapid clot development at the injury site, subsequently being naturally absorbed by the body once its purpose is fulfilled. An illustrative example is Baxter International Inc., a US-based healthcare firm, which introduced PERCLOT absorbable hemostatic powder in July 2023. PERCLOT granules are characterized by a distinct molecular architecture that quickly draws in water, forming a gel-like adhesive matrix. This matrix establishes a physical impediment to bleeding by encouraging the aggregation of platelets, red blood cells, and crucial coagulation proteins such as thrombin and fibrinogen. Such an attribute significantly boosts clinicians’ capacity to address a wider array of intraoperative bleeding scenarios, which is vital for decreasing the requirement for blood transfusions, mitigating severe complications, and ultimately diminishing the total expense of medical care.

Which Key Players Are Active In The Absorbable Hemostats Market?

Major companies operating in the absorbable hemostats market are Johnson & Johnson, Medtronic Plc, Baxter International Inc., B. Braun Melsungen AG, Integra LifeSciences, Acelity, Meril Life Sciences Pvt. Ltd., Gelita AG, CryoLife Inc., Anika Therapeutics Inc., Z-Medica LLC, Cohera Medical Inc., Marine Polymer Technologies Inc., Curasan AG, Hemostasis LLC, Arch Therapeutics Inc., Cura Medical, FzioMed Inc., Guizhou Jin Jiu Biotech Co. Ltd., Omrix Biopharmaceuticals Inc.

Access The Complete Absorbable Hemostats Market Report:

https://www.thebusinessresearchcompany.com/report/absorbable-hemostats-global-market-report

Which Region Accounts For The Highest Share Of The Absorbable Hemostats Market?

North America was the largest region in the absorbable hemostats market in 2025. The regions covered in the absorbable hemostats market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Absorbable Hemostats Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=18777&type=smp

Browse Through More Reports Similar to the Global Absorbable Hemostats Market 2026, By The Business Research Company

Hemostats Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemostats-global-market-report

Hemostasis Products Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemostasis-products-global-market-report

Hemostasis Diagnostic Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemostasis-diagnostic-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

By 2030, What Market Size Is The Absorbable Hemostats Market Expected To Reach Based On Its 2026 Value?

The absorbable hemostats market has experienced significant growth in recent years. Its value is anticipated to rise from $3.37 billion in 2025 to $3.63 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.8%. The historical expansion of this market can be attributed to factors such as an increasing volume of neurosurgery and orthopedic surgery procedures, a rising demand for products that control intraoperative bleeding, the growing adoption of oxidized regenerated cellulose and gelatin-based hemostats, the expansion of hospital surgical infrastructure and operating rooms, and increasing clinical acceptance of absorbable biomaterial hemostats.

The absorbable hemostats market is projected to experience substantial expansion in the coming years. It is anticipated to reach $4.96 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.1%. This growth during the forecast period is propelled by factors such as the increasing application of advanced thrombin and collagen-based products, a growing inclination towards minimally invasive and reconstructive surgical procedures, heightened investment in novel bioabsorbable and hybrid hemostat solutions, an expansion in the number of procedures conducted in ambulatory surgical centers, and an increased emphasis on minimizing surgical complications and optimizing recovery periods. Key trends anticipated during the same period encompass the advancing development of bioengineered absorbable hemostat materials for improved tissue compatibility, a surging embrace of sophisticated collagen, gelatin, and thrombin-based hemostats in intricate surgical operations, a growing demand for versatile hemostatic products that promote swift clot stabilization and effective wound healing, broadened use of absorbable hemostats in both minimally invasive and reconstructive surgeries, and an intensified clinical emphasis on hemostats engineered to mitigate post-operative complications and risks of surgical bleeding.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18777&type=smp

What Significant Factors Are Influencing The Absorbable Hemostats Market Expansion?

The expansion of the absorbable hemostats market is projected to be driven by an increasing volume of surgical operations. Surgical procedures encompass medical interventions executed to treat, diagnose, or manage conditions by physically altering tissues or organs via incisions or other techniques. This uptick in procedures is attributed to a rising demand for advanced medical treatments, an aging population globally, and advancements in surgical technology enabling more intricate and minimally invasive operations. Absorbable hemostats are vital during these procedures for controlling bleeding and fostering clot formation, as they are gradually absorbed by the body, thereby diminishing the requirement for additional interventions and lessening postoperative complications. For instance, in April 2025, the British Association of Aesthetic Plastic Surgeons, a professional body based in the UK, reported that 25,972 surgical procedures were carried out in 2023. Women represented 93% of all cosmetic surgeries performed, while men constituted the remaining 7% of these cases. Thus, the escalating number of surgical procedures is a primary growth driver for the absorbable hemostats market.

Which Segment Types Are Examined In The Absorbable Hemostats Market Segment Study?

The absorbable hemostats market covered in this report is segmented –

1) By Type: Thrombin-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Gelatin-Based Hemostats, Collagen-Based Hemostats, Other Types

2) By Application: Neurosurgery, Orthopedic Surgery, General Surgery, Reconstructive Surgery, Other Applications

3) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Thrombin-Based Hemostats: Lyophilized Thrombin Hemostats, Liquid Thrombin-Based Hemostats

2) By Oxidized Regenerated Cellulose-Based Hemostats: Pre-Packaged Oxidized Cellulose Hemostats, Customizable Oxidized Cellulose Products

3) By Gelatin-Based Hemostats: Gelatin Sponge-Based Hemostats, Gelatin Foam-Based Hemostats

4) By Collagen-Based Hemostats: Collagen-Based Pads or Sheets, Collagen-Based Sponges or Powder

5) By Other Types: Fibrin-Based Hemostats, Polymeric-Based Hemostats, Other Innovative Or Hybrid Formulations

What Trends Are Affecting The Direction Of The Absorbable Hemostats Market?

Leading companies in the absorbable hemostats market are focusing on developing advanced products, such as absorbable hemostatic powder, to ensure quick and effective bleeding control during surgical procedures. This absorbable hemostatic powder is a medical product used to manage bleeding by promoting rapid clot formation at the injury site, and it is naturally absorbed by the body after its function is complete. For example, in July 2023, Baxter International Inc., a US-based healthcare firm, introduced PERCLOT absorbable hemostatic powder. PERCLOT granules feature a distinct molecular structure that quickly absorbs water, creating a gelled adhesive matrix that forms a mechanical barrier to stop bleeding by encouraging the buildup of platelets, red blood cells, and coagulation proteins such as thrombin and fibrinogen. This capability enhances clinicians’ proficiency in managing a wider spectrum of intraoperative bleeding, which is essential for reducing the demand for blood transfusions, minimizing significant complications, and ultimately decreasing the overall cost of patient care.

Which Players Are Part Of The Competitive Landscape Of The Absorbable Hemostats Market?

Major companies operating in the absorbable hemostats market are Johnson & Johnson, Medtronic Plc, Baxter International Inc., B. Braun Melsungen AG, Integra LifeSciences, Acelity, Meril Life Sciences Pvt. Ltd., Gelita AG, CryoLife Inc., Anika Therapeutics Inc., Z-Medica LLC, Cohera Medical Inc., Marine Polymer Technologies Inc., Curasan AG, Hemostasis LLC, Arch Therapeutics Inc., Cura Medical, FzioMed Inc., Guizhou Jin Jiu Biotech Co. Ltd., Omrix Biopharmaceuticals Inc.

Get The Full Absorbable Hemostats Market Report:

https://www.thebusinessresearchcompany.com/report/absorbable-hemostats-global-market-report

Which Region Leads The Absorbable Hemostats Market In Overall Market Size?

North America was the largest region in the absorbable hemostats market in 2025. The regions covered in the absorbable hemostats market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Absorbable Hemostats Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=18777&type=smp

Browse Through More Reports Similar to the Global Absorbable Hemostats Market 2026, By The Business Research Company

Hemostats Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemostats-global-market-report

Hemostasis Products Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemostasis-products-global-market-report

Hemostasis Diagnostic Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemostasis-diagnostic-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Will The Market Size Of The Absorbable Hemostats Market Evolve From 2026 To 2030?

The absorbable hemostats market has experienced robust expansion over the past few years. Projections indicate it will expand from $3.37 billion in 2025 to $3.63 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.8%. This historical growth can be linked to several factors, including a rise in neurosurgery and orthopedic surgery procedures, an escalating need for products that control bleeding during operations, wider acceptance of oxidized regenerated cellulose and gelatin-based hemostats, the expansion of surgical facilities and operating rooms within hospitals, and increased clinical approval of absorbable biomaterial hemostats.

The absorbable hemostats market is projected to experience substantial growth over the next few years, with an anticipated expansion to $4.96 billion by 2030, reflecting a compound annual growth rate (CAGR) of 8.1%. This projected growth within the forecast period can be attributed to several factors, including the increasing application of advanced thrombin and collagen-based formulations, a growing inclination towards minimally invasive and reconstructive surgical techniques, heightened investment in bioabsorbable and hybrid hemostat innovations, an increase in procedure volumes at ambulatory surgical centers, and a stronger focus on mitigating surgical complications and accelerating recovery times. Prominent trends for the upcoming period include the progressive development of bioengineered absorbable hemostat materials engineered for superior tissue compatibility, the expanding adoption of advanced collagen, gelatin, and thrombin-based hemostats in complex surgical interventions, a rising preference for multifunctional hemostatic products that promote rapid clot stabilization and wound healing, the broadened utilization of absorbable hemostats in minimally invasive and reconstructive surgeries, and an intensified clinical emphasis on hemostats specifically designed to reduce post-operative complications and the risks of surgical bleeding.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18777&type=smp

What Key Drivers Are Influencing The Growth Of The Absorbable Hemostats Market?

The absorbable hemostats market is anticipated to expand due to a rising volume of surgical procedures going forward. These procedures involve medical operations performed to treat, diagnose, or manage conditions by physically altering tissues or organs through incisions or other techniques. The increase in surgical interventions stems from a growing demand for advanced medical treatments, an aging population, and breakthroughs in surgical technology that facilitate more complex and minimally invasive operations. Absorbable hemostats are employed in surgical procedures to control bleeding and promote clot formation while being gradually absorbed by the body, thereby reducing the necessity for additional interventions and minimizing postoperative complications. For instance, in April 2025, according to the British Association of Aesthetic Plastic Surgeons, a UK-based professional organization, a total of 25,972 surgical procedures were performed in 2023, with women representing 93% of all cosmetic surgeries. Men made up the remaining 7% of these cases. Consequently, the increasing number of surgical procedures is driving the growth of the absorbable hemostats market.

Which Segment Areas Are Covered In The Absorbable Hemostats Market Analysis?

The absorbable hemostats market covered in this report is segmented –

1) By Type: Thrombin-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Gelatin-Based Hemostats, Collagen-Based Hemostats, Other Types

2) By Application: Neurosurgery, Orthopedic Surgery, General Surgery, Reconstructive Surgery, Other Applications

3) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Thrombin-Based Hemostats: Lyophilized Thrombin Hemostats, Liquid Thrombin-Based Hemostats

2) By Oxidized Regenerated Cellulose-Based Hemostats: Pre-Packaged Oxidized Cellulose Hemostats, Customizable Oxidized Cellulose Products

3) By Gelatin-Based Hemostats: Gelatin Sponge-Based Hemostats, Gelatin Foam-Based Hemostats

4) By Collagen-Based Hemostats: Collagen-Based Pads or Sheets, Collagen-Based Sponges or Powder

5) By Other Types: Fibrin-Based Hemostats, Polymeric-Based Hemostats, Other Innovative Or Hybrid Formulations

What Key Developments And Trends Are Impacting The Absorbable Hemostats Market?

Leading companies in the absorbable hemostats market are concentrating on the development of advanced products, such as absorbable hemostatic powder, to ensure swift and effective bleeding control during surgical procedures. Absorbable hemostatic powder is a medical solution designed to manage bleeding by fostering rapid clot formation at the injury site, which the body then naturally absorbs once its function is complete. For instance, in July 2023, Baxter International Inc., a US-based healthcare company, launched PERCLOT absorbable hemostatic powder. The unique molecular structure of PERCLOT granules allows for rapid water absorption, forming a gelled adhesive matrix that establishes a mechanical barrier to stop bleeding by promoting the aggregation of platelets, red blood cells, and coagulation proteins like thrombin and fibrinogen. This capability significantly improves clinicians’ ability to manage a wider array of intraoperative bleeding, which is critical for reducing the requirement for blood transfusions, minimizing major complications, and ultimately decreasing the overall cost of care.

Which Global Companies Are Actively Competing In The Absorbable Hemostats Market?

Major companies operating in the absorbable hemostats market are Johnson & Johnson, Medtronic Plc, Baxter International Inc., B. Braun Melsungen AG, Integra LifeSciences, Acelity, Meril Life Sciences Pvt. Ltd., Gelita AG, CryoLife Inc., Anika Therapeutics Inc., Z-Medica LLC, Cohera Medical Inc., Marine Polymer Technologies Inc., Curasan AG, Hemostasis LLC, Arch Therapeutics Inc., Cura Medical, FzioMed Inc., Guizhou Jin Jiu Biotech Co. Ltd., Omrix Biopharmaceuticals Inc.

Read the full absorbable hemostats market report here:

https://www.thebusinessresearchcompany.com/report/absorbable-hemostats-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Absorbable Hemostats Market?

North America was the largest region in the absorbable hemostats market in 2025. The regions covered in the absorbable hemostats market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Absorbable Hemostats Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=18777&type=smp

Browse Through More Reports Similar to the Global Absorbable Hemostats Market 2026, By The Business Research Company

Hemostats Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemostats-global-market-report

Hemostasis Products Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemostasis-products-global-market-report

Hemostasis Diagnostic Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemostasis-diagnostic-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the application programming interface (api) economy market from 2026–2035 with trusted insights from The Business Research Company

What level of CAGR-driven expansion is anticipated in the Absorbable Hemostats Market between 2026 and 2030?

The absorbable hemostats market has experienced robust expansion in recent years. It is projected to increase from $3.37 billion in 2025 to $3.63 billion in 2026, advancing at a compound annual growth rate (CAGR) of 7.8%. The historical growth within this market can be attributed to factors such as a greater volume of neurosurgery and orthopedic surgery procedures, an escalating demand for intraoperative bleeding control products, the widening adoption of oxidized regenerated cellulose and gelatin-based hemostats, the expansion of hospital surgical infrastructure and operating rooms, and the increasing clinical acceptance of absorbable biomaterial hemostats.

The absorbable hemostats market is projected to experience substantial expansion over the coming years, with its size expected to reach $4.96 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.1%. This growth during the forecast period is primarily attributable to several factors, including the increasing application of sophisticated thrombin and collagen-based products, a noticeable shift towards minimally invasive and reconstructive surgical techniques, heightened investment in novel bioabsorbable and hybrid hemostat technologies, an increase in procedures performed at ambulatory surgical centers, and a greater emphasis on minimizing surgical complications and accelerating patient recovery. Key trends anticipated during this period involve the enhanced development of bioengineered absorbable hemostat materials to improve tissue compatibility, the growing use of advanced collagen, gelatin, and thrombin-based hemostats in intricate surgical operations, a rising demand for versatile hemostatic solutions that facilitate quick clot stabilization and wound recovery, broader application of absorbable hemostats in both minimally invasive and reconstructive surgeries, and a heightened clinical interest in hemostats engineered to mitigate post-operative issues and surgical bleeding risks.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18777&type=smp

What Drivers Are Affecting Demand-Supply Dynamics In The Absorbable Hemostats Market?

The absorbable hemostats market is projected to grow as the number of surgical procedures continues to increase. Surgical procedures are medical interventions performed to diagnose, treat, or manage various conditions by physically altering tissues or organs through incisions or other methods. This rise in surgical procedures can be attributed to a growing demand for advanced medical treatments, an aging global population, and progress in surgical technology enabling more complex yet minimally invasive operations. Absorbable hemostats are critical in these procedures for managing bleeding and encouraging clot formation, as they are slowly absorbed by the body, thereby reducing the necessity for further interventions and mitigating postoperative complications. For instance, in April 2025, the British Association of Aesthetic Plastic Surgeons, a UK-based professional organization, reported that a total of 25,972 surgical procedures were conducted in 2023, with women accounting for 93% of all cosmetic surgeries, and men representing the remaining 7%. Consequently, the growing volume of surgical procedures is a key driver for the absorbable hemostats market.

What Segments Are Included Within The Absorbable Hemostats Market?

The absorbable hemostats market covered in this report is segmented –

1) By Type: Thrombin-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Gelatin-Based Hemostats, Collagen-Based Hemostats, Other Types

2) By Application: Neurosurgery, Orthopedic Surgery, General Surgery, Reconstructive Surgery, Other Applications

3) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Thrombin-Based Hemostats: Lyophilized Thrombin Hemostats, Liquid Thrombin-Based Hemostats

2) By Oxidized Regenerated Cellulose-Based Hemostats: Pre-Packaged Oxidized Cellulose Hemostats, Customizable Oxidized Cellulose Products

3) By Gelatin-Based Hemostats: Gelatin Sponge-Based Hemostats, Gelatin Foam-Based Hemostats

4) By Collagen-Based Hemostats: Collagen-Based Pads or Sheets, Collagen-Based Sponges or Powder

5) By Other Types: Fibrin-Based Hemostats, Polymeric-Based Hemostats, Other Innovative Or Hybrid Formulations

Which Trends Are Guiding The Evolution Of The Absorbable Hemostats Market?

Leading companies in the absorbable hemostats market are concentrating on developing advanced products, such as absorbable hemostatic powder, to provide swift and effective bleeding control during surgery. This absorbable hemostatic powder is a medical solution designed to halt bleeding by encouraging quick clot development at the injury site, subsequently being naturally absorbed by the body once its purpose is served. As an illustration, in July 2023, Baxter International Inc., a US-based healthcare company, introduced its PERCLOT absorbable hemostatic powder. PERCLOT granules feature a distinct molecular design that quickly draws in water, creating a gel-like adhesive matrix. This matrix establishes a physical barrier to cease bleeding by fostering the collection of platelets, red blood cells, and clotting proteins such as thrombin and fibrinogen. This characteristic improves clinicians’ capacity to address a wider spectrum of bleeding encountered during operations, which is vital for decreasing the necessity for blood transfusions, mitigating significant complications, and eventually reducing the comprehensive expenses of patient care.

Who Are The Top-Performing Companies In The Absorbable Hemostats Market In Recent Years?

Major companies operating in the absorbable hemostats market are Johnson & Johnson, Medtronic Plc, Baxter International Inc., B. Braun Melsungen AG, Integra LifeSciences, Acelity, Meril Life Sciences Pvt. Ltd., Gelita AG, CryoLife Inc., Anika Therapeutics Inc., Z-Medica LLC, Cohera Medical Inc., Marine Polymer Technologies Inc., Curasan AG, Hemostasis LLC, Arch Therapeutics Inc., Cura Medical, FzioMed Inc., Guizhou Jin Jiu Biotech Co. Ltd., Omrix Biopharmaceuticals Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/absorbable-hemostats-global-market-report

Which Region Currently Holds The Largest Share Of The Absorbable Hemostats Market?

North America was the largest region in the absorbable hemostats market in 2025. The regions covered in the absorbable hemostats market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Absorbable Hemostats Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=18777&type=smp

Browse Through More Reports Similar to the Global Absorbable Hemostats Market 2026, By The Business Research Company

Hemostats Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemostats-global-market-report

Hemostasis Products Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemostasis-products-global-market-report

Hemostasis Diagnostic Devices And Equipment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemostasis-diagnostic-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Uncover key drivers, emerging technologies, and competitive movements shaping the absorbable hemostats market from 2025–2034 with trusted insights from The Business Research Company

What Are The Future Growth Projections For The Absorbable Hemostats Market Size?

The absorbable hemostats market has demonstrated significant growth in recent years. Its valuation is projected to increase from $23.59 billion in 2024 to $24.85 billion in 2025, achieving a compound annual growth rate (CAGR) of 5.3%. This historical growth can be attributed to advancements in surgical techniques, the rising incidence of chronic diseases, a growing preference for minimally invasive surgeries, continuous improvements in hemostatic materials, and an enhanced focus on patient safety.

The absorbable hemostats market anticipates significant expansion in the coming years, with projections indicating it will reach $31.29 billion by 2029, driven by a compound annual growth rate (CAGR) of 5.9%. This expansion during the forecast period is primarily fueled by factors such as an increasing elderly population, a heightened focus on personalized medicine, growing healthcare spending, broader healthcare infrastructure, and a higher occurrence of trauma and medical emergencies. Key trends expected during this period involve the creation of versatile hemostatic products, incorporating smart technologies for continuous monitoring, increased utilization of bioengineered substances, a surge in strategic alliances, and improvements in regulatory frameworks.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18777&type=smp

What Core Market Drivers Are Expanding The Absorbable Hemostats Industry?

A projected increase in surgical procedures is expected to propel the growth of the absorbable hemostats market moving forward. Surgical procedures are medical operations performed to treat, diagnose, or manage various conditions by physically altering tissues or organs through incisions or other techniques. The surge in surgical procedures can be attributed to the rising demand for advanced medical treatments, an expanding aging population, and breakthroughs in surgical technology that enable more complex and minimally invasive operations. Absorbable hemostats are utilized in surgical settings to control bleeding and promote clot formation, while being gradually absorbed by the body, thus reducing the need for additional interventions and minimizing postoperative complications. For instance, in March 2023, the British Association of Aesthetic Plastic Surgeons, a UK-based surgical organization, reported 31,057 cosmetic procedures in 2022, indicating a 102% increase from the prior year. Therefore, the growing number of surgical procedures is fueling the expansion of the absorbable hemostasis market.

What Segment Insights Are Highlighted In The Absorbable Hemostats Market Report?

The absorbable hemostatsmarket covered in this report is segmented –

1) By Type: Thrombin-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Gelatin-Based Hemostats, Collagen-Based Hemostats, Other Types

2) By Application: Neurosurgery, Orthopedic Surgery, General Surgery, Reconstructive Surgery, Other Applications

3) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Thrombin-Based Hemostats: Lyophilized Thrombin Hemostats, Liquid Thrombin-Based Hemostats

2) By Oxidized Regenerated Cellulose-Based Hemostats: Pre-Packaged Oxidized Cellulose Hemostats, Customizable Oxidized Cellulose Products

3) By Gelatin-Based Hemostats: Gelatin Sponge-Based Hemostats, Gelatin Foam-Based Hemostats

4) By Collagen-Based Hemostats: Collagen-Based Pads or Sheets, Collagen-Based Sponges or Powder

5) By Other Types: Fibrin-Based Hemostats, Polymeric-Based Hemostats, Other Innovative Or Hybrid Formulations

Which Notable Trends Are Transforming The Absorbable Hemostats Market Outlook?

Major companies in the absorbable hemostats market are concentrating on the creation of advanced products, including absorbable hemostatic powder, to ensure swift and efficient bleeding management during surgery. This medical product functions by stimulating rapid clot formation at the wound site to control bleeding, and the body naturally assimilates it after its purpose is fulfilled. As an example, in July 2023, Baxter International Inc., a US-based healthcare company, launched PERCLOT absorbable hemostatic powder. The granules of PERCLOT possess a distinct molecular structure that rapidly takes in water, forming an adhesive gel matrix. This matrix then creates a mechanical barrier, halting bleeding by encouraging the aggregation of platelets, red blood cells, and coagulation proteins such as thrombin and fibrinogen. This feature significantly improves clinicians’ capacity to handle a wider range of intraoperative bleeding, which is crucial for reducing the necessity for blood transfusions, minimizing severe complications, and ultimately lowering the overall expenses of care.

Which Firms Are Driving Innovation Within The Absorbable Hemostats Market?

Major companies operating in the absorbable hemostats market are Johnson & Johnson, Medtronic Plc, Becton, Dickinson and Company, Stryker Corporation, Baxter International Inc., CSL Behring, B. Braun Melsungen AG, Teleflex Incorporated, Samyang Holdings Corporation, Integra LifeSciences, Acelity, Meril Life Sciences Pvt. Ltd., Gelita AG, CryoLife Inc., Anika Therapeutics Inc., Z-Medica LLC, Cohera Medical Inc., Marine Polymer Technologies Inc., Curasan AG, Hemostasis LLC, Arch Therapeutics Inc., Cura Medical, Ferrosan Medical Devices A/S, FzioMed Inc., Guizhou Jin Jiu Biotech Co. Ltd.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/absorbable-hemostats-global-market-report

What Regional Trends Are Shaping Growth In The Absorbable Hemostats Market?

North America was the largest region in the absorbable hemostats market in 2024. The regions covered in the absorbable hemostats market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=18777&type=smp

Browse Through More Reports Similar to the Global Absorbable Hemostats Market 2025, By The Business Research Company

Hemostasis Analyzers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hemostasis-analyzers-global-market-report

Hemostasis Diagnostic Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hemostasis-diagnostic-devices-and-equipment-global-market-report

Hemodialysis And Peritoneal Dialysis Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hemodialysis-and-peritoneal-dialysis-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Expected Total Market Size Of The Absorbable Hemostats Industry By The Forecast Year 2029?

The market concerning absorbable hemostats has experienced robust expansion over the past few years, projected to increase its valuation from $23.59 billion in 2024 to $24.85 billion across 2025, reflecting a compound annual growth rate of 5.3 percent. This notable upward trend observed during the historical span is attributable to a confluence of factors, including progress in surgical methodologies, a higher incidence of long-term illnesses, escalating requirements for procedures involving minimal invasion, significant enhancements in the materials utilized for stopping bleeding, and greater emphasis placed upon safeguarding patient well-being.

Projections indicate robust expansion for the absorbable hemostats market over the coming years, reaching a valuation of $31.29 billion by 2029, driven by a compound annual growth rate (CAGR) of 5.9%; this upsurge during the forecasted interval is underpinned by several factors, notably the increasing elderly demographic, greater focus on tailored medical treatments, escalating medical spending, the broadening of medical facilities, and a higher frequency of accidental injuries and urgent medical situations, while significant market movements anticipated include the creation of hemostatic solutions offering multiple functionalities, the incorporation of intelligent systems for continuous performance tracking, increased adoption of materials produced via bioengineering, a surge in cooperative agreements and alliances, and progress in setting regulatory benchmarks.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18777&type=smp

What Are The Main Drivers Boosting The Absorbable Hemostats Industry’s Expansion?

A surge in surgical operations is anticipated to fuel the expansion of the absorbable hemostats market moving ahead. These medical interventions, which involve physical modification of tissues or organs via incisions or alternative methods for diagnosing, treating, or managing ailments, are becoming more frequent owing to greater need for sophisticated medical care, an older demographic, and progress in surgical methods that allow for more intricate and less invasive surgeries. Absorbable hemostats play a vital role in these procedures by stemming blood loss and aiding coagulation while the body naturally breaks them down, thereby lessening the requirement for subsequent procedures and cutting down on post-operation issues. To illustrate this trend, data from the British Association of Aesthetic Plastic Surgeons, a UK surgical body, revealed that in 2022, there were 31,057 cosmetic operations, representing a substantial 102 percent climb compared to the preceding year, as reported in March 2023, compellingly demonstrating how the rising volume of surgeries is propelling the absorbable hemostasis market forward.

How Is The Absorbable Hemostats Market Segmented?

The absorbable hemostatsmarket covered in this report is segmented –

1) By Type: Thrombin-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Gelatin-Based Hemostats, Collagen-Based Hemostats, Other Types

2) By Application: Neurosurgery, Orthopedic Surgery, General Surgery, Reconstructive Surgery, Other Applications

3) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Thrombin-Based Hemostats: Lyophilized Thrombin Hemostats, Liquid Thrombin-Based Hemostats

2) By Oxidized Regenerated Cellulose-Based Hemostats: Pre-Packaged Oxidized Cellulose Hemostats, Customizable Oxidized Cellulose Products

3) By Gelatin-Based Hemostats: Gelatin Sponge-Based Hemostats, Gelatin Foam-Based Hemostats

4) By Collagen-Based Hemostats: Collagen-Based Pads or Sheets, Collagen-Based Sponges or Powder

5) By Other Types: Fibrin-Based Hemostats, Polymeric-Based Hemostats, Other Innovative Or Hybrid Formulations

Which Competitive Trends Are Defining The Absorbable Hemostats Market Structure?

Leading firms operating within the absorbable hemostats sector are concentrating their efforts on innovating sophisticated offerings, notably absorbable hemostatic powder, aimed at delivering swift and potent hemorrhage management during surgical procedures. This hemostatic powder, designed for medical application, serves to arrest blood loss by accelerating clot genesis directly at the trauma area, subsequently being metabolized harmlessly by the body once its hemostatic duty is complete. As an illustration of this sector activity, in July of 2023, Baxter International Inc., a corporation headquartered in the United States specializing in healthcare solutions, introduced PERCLOT absorbable hemostatic powder to the market. The PERCLOT particles feature a distinctive molecular makeup that quickly soaks up fluid, thereby fabricating a gelatinous adhesive film which establishes a physical barricade against blood flow through encouraging the aggregation of platelets, erythrocytes, and clotting factors such as thrombin and fibrinogen. This specific characteristic significantly bolsters medical practitioners’ capacity to handle a wider spectrum of intraoperative bleeding scenarios, a capability vital for decreasing reliance on allogeneic blood products, mitigating serious adverse events, and consequently driving down total treatment expenses.

Which Global Market Leaders Are Shaping The Future Of The Absorbable Hemostats Sector?

Major companies operating in the absorbable hemostats market are Johnson & Johnson, Medtronic Plc, Becton, Dickinson and Company, Stryker Corporation, Baxter International Inc., CSL Behring, B. Braun Melsungen AG, Teleflex Incorporated, Samyang Holdings Corporation, Integra LifeSciences, Acelity, Meril Life Sciences Pvt. Ltd., Gelita AG, CryoLife Inc., Anika Therapeutics Inc., Z-Medica LLC, Cohera Medical Inc., Marine Polymer Technologies Inc., Curasan AG, Hemostasis LLC, Arch Therapeutics Inc., Cura Medical, Ferrosan Medical Devices A/S, FzioMed Inc., Guizhou Jin Jiu Biotech Co. Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/absorbable-hemostats-global-market-report

Which Region Is Expected To Witness The Fastest Growth In The Absorbable Hemostats Market?

North America was the largest region in the absorbable hemostats market in 2024. The regions covered in the absorbable hemostats market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Absorbable Hemostats Market Report:

https://www.thebusinessresearchcompany.com/customise?id=18777&type=smp

Browse Through More Reports Similar to the Global Absorbable Hemostats Market 2025, By The Business Research Company

Hemostasis Analyzers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hemostasis-analyzers-global-market-report

Hemostasis Diagnostic Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hemostasis-diagnostic-devices-and-equipment-global-market-report

Hemodialysis And Peritoneal Dialysis Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hemodialysis-and-peritoneal-dialysis-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Fast Is The Absorbable Hemostats Market Expected to Grow Between 2025 And 2029?

The market size for absorbable hemostats has notably expanded in recent times. Its growth which will see it rise from $23.59 billion in 2024 to $25.05 billion in 2025, indicates a compound annual growth rate (CAGR) of 6.2%. The progression during the previous period can be linked to advancements in surgical procedures, a surge in chronic diseases, increased interest in minimally invasive operations, progress in hemostatic materials, and heightened emphasis on patient safety.

What Growth Rate Is Anticipated for the Absorbable Hemostats Market in the Coming Years?

The market for absorbable hemostats is expected to witness substantial expansion in the coming years, with its magnitude escalating to $31.39 billion by the year 2029, reflecting a compound annual growth rate (CAGR) of 5.8%. This robust increase during the forecast period can be ascribed to factors such as an aging populace, growing focus on individualized medication, increased healthcare spending, enhancement of healthcare facilities, and heightened occurrences of trauma and emergencies. The dominant trends projected in the forecast period encompass progress in multi-purpose hemostatic products, fusion of innovative technologies for real-time surveillance, rising utilization of bioengineered resources, an upsurge in alliances and collaborations, and advancements in regulatory norms.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18777&type=smp

Who Are the Leading Companies in the Absorbable Hemostats Market?

Major companies operating in the absorbable hemostats market are Johnson & Johnson, Medtronic Plc, Becton, Dickinson and Company, Stryker Corporation, Baxter International Inc., CSL Behring, B. Braun Melsungen AG, Teleflex Incorporated, Samyang Holdings Corporation, Integra LifeSciences, Acelity, Meril Life Sciences Pvt. Ltd., Gelita AG, CryoLife Inc., Anika Therapeutics Inc., Z-Medica LLC, Cohera Medical Inc., Marine Polymer Technologies Inc., Curasan AG, Hemostasis LLC, Arch Therapeutics Inc., Cura Medical, Ferrosan Medical Devices A/S, FzioMed Inc., Guizhou Jin Jiu Biotech Co. Ltd.

What Are the Key Drivers of the Absorbable Hemostats Market?

The surge in the number of surgical procedures is playing a significant role in propelling the growth of the absorbable hemostats market. These procedures, used to treat, diagnose, or manage conditions, entail the physical modification of tissues or organs via incisions or alternative methods. This surge is a result of an increasing need for advanced medical treatments, an aging demographic, and enhancements in surgical technology that make possible more intricate and less invasive procedures. Absorbable hemostats are implemented during these procedures to stem bleeding and aid clot formation and are gradually ingested into the body, reducing the necessity for subsequent interventions and lowering postoperative complications. For example, the British Association of Aesthetic Plastic Surgeons, a UK-based surgical organization, reported that there were 31,057 cosmetic procedures in 2022, which represented a 102% surge from the former year. Thus, the rise in the number of surgical procedures is powering the growth of the absorbable hemostasis market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=18777&type=smp

What Are the Key Market Segments in the Absorbable Hemostats Industry?

The absorbable hemostats market covered in this report is segmented –

1) By Type: Thrombin-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Gelatin-Based Hemostats, Collagen-Based Hemostats, Other Types

2) By Application: Neurosurgery, Orthopedic Surgery, General Surgery, Reconstructive Surgery, Other Applications

3) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Thrombin-Based Hemostats: Lyophilized Thrombin Hemostats, Liquid Thrombin-Based Hemostats

2) By Oxidized Regenerated Cellulose-Based Hemostats: Pre-Packaged Oxidized Cellulose Hemostats, Customizable Oxidized Cellulose Products

3) By Gelatin-Based Hemostats: Gelatin Sponge-Based Hemostats, Gelatin Foam-Based Hemostats

4) By Collagen-Based Hemostats: Collagen-Based Pads or Sheets, Collagen-Based Sponges or Powder

5) By Other Types: Fibrin-Based Hemostats, Polymeric-Based Hemostats, Other Innovative Or Hybrid Formulations

What Are the Latest Trends in the Absorbable Hemostats Market?

Leading enterprises in the absorbable hemostats market are putting their efforts into creating more advanced products like absorbable hemostatic powder, designed for quick and effective bleeding management during surgical procedures. This medical product aids in clotting at the wound site, and is eventually absorbed naturally by the body once it has served its purpose. Baxter International Inc., a healthcare firm based in the US, introduced PERCLOT absorbable hemostatic powder in July 2023 as an example. The unique molecular composition of PERCLOT granules allows swift absorption of water, leading to a gelled adhesive matrix formation. It generates a mechanical barrier to halt bleeding by facilitating the buildup of platelets, red blood cells, and coagulation proteins like thrombin and fibrinogen. This particular feature augments clinicians’ capability to control a larger spectrum of intraoperative bleeding more efficiently. Consequently, it reduces the requirement for blood transfusions, decreases major complications occurrence, and ultimately trims down the total cost of care.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/absorbable-hemostats-global-market-report

What Are the Key Regional Markets in the Absorbable Hemostats Industry?

North America was the largest region in the absorbable hemostats market in 2024. The regions covered in the absorbable hemostats market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18777

This Report Delivers Insight On:

1. How big is the absorbable hemostats market, and how is it changing globally?

2. Who are the major companies in the absorbable hemostats market, and how are they performing?

3. What are the key opportunities and risks in the absorbable hemostats market right now?

4. Which products or customer segments are growing the most in the absorbable hemostats market?

5. What factors are helping or slowing down the growth of the absorbable hemostats market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the absorbable hemostats industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#What is the Projected CAGR for the Absorbable Hemostats Market Size from 2025 to 2034?#_x000D_

The market size of absorbable hemostats has witnessed robust growth in the past few years. Its value is anticipated to rise from $23.59 billion in 2024 to $25.05 billion in 2025, boasting a compound annual growth rate (CAGR) of 6.2%. The development seen during the historic period has been fueled by advancements in surgical methodologies, a growing incidence of chronic illnesses, an upsurge in the need for minimally invasive surgeries, progress in hemostatic substances, and an increased consciousness about patient safety._x000D_

_x000D_

In the coming years, a robust growth is anticipated in the market size of absorbable hemostats. It is projected that by 2029, it will reach a value of $31.39 billion, expanding at a compound annual growth rate (CAGR) of 5.8%. Factors contributing to this expected growth during the forecasted period include the increasing elder population, the growing focus on personalized medical treatments, a rise in healthcare spending, expanding healthcare infrastructure, and growing instances of trauma and emergencies. Key trends to watch in this space during the forecast period are the creation of multi-purpose hemostatic products, the integration of intelligent technology for live monitoring, the rising utilization of bioengineered materials, an increase in partnerships and collaborations, and progress in regulatory standards._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=18777&type=smp_x000D_

_x000D_

#How Are Key Drivers in the Industry Acting as Catalysts for the Growth of the Absorbable Hemostats Market?#_x000D_

Absorbable hemostats market’s growth is anticipated to be driven by the rising number of surgical procedures. Medical operations aimed at managing, diagnosing, or treating conditions by physically modifying tissues or organs via cuts or other methodologies are defined as surgical procedures. The escalation in these procedures can be attributed to the growing demand for progressive medical treatments, an aging populace, and breakthroughs in surgical technology that facilitate more intricate and less invasive operations. Absorbable hemostats, which help regulate bleeding and support clot formation while being slowly assimilated by the body, are employed during surgical procedures. This reduces the necessity for extra interventions and lessens postoperative complications. For example, the British Association of Aesthetic Plastic Surgeons, a surgical organization based in the UK, reported in March 2023, that in 2022 there were 31,057 cosmetic procedures, indicating a 102% increase from the prior year. Consequently, the escalating volume of surgical procedures is propelling the growth of the absorbable hemostasis market._x000D_

_x000D_

#Which Segments in the Absorbable Hemostats Offer the Most Growth?#_x000D_

The absorbable hemostats market covered in this report is segmented –_x000D_

_x000D_

1) By Type: Thrombin-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Gelatin-Based Hemostats, Collagen-Based Hemostats, Other Types_x000D_

2) By Application: Neurosurgery, Orthopedic Surgery, General Surgery, Reconstructive Surgery, Other Applications_x000D_

3) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Other End-Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Thrombin-Based Hemostats: Lyophilized Thrombin Hemostats, Liquid Thrombin-Based Hemostats_x000D_

2) By Oxidized Regenerated Cellulose-Based Hemostats: Pre-Packaged Oxidized Cellulose Hemostats, Customizable Oxidized Cellulose Products_x000D_

3) By Gelatin-Based Hemostats: Gelatin Sponge-Based Hemostats, Gelatin Foam-Based Hemostats_x000D_

4) By Collagen-Based Hemostats: Collagen-Based Pads or Sheets, Collagen-Based Sponges or Powder_x000D_

5) By Other Types: Fibrin-Based Hemostats, Polymeric-Based Hemostats, Other Innovative Or Hybrid Formulations_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=18777&type=smp_x000D_

_x000D_

#What Are the Fastest-Growing Geographies in the Absorbable Hemostats Market?#_x000D_

North America was the largest region in the absorbable hemostats market in 2024. The regions covered in the absorbable hemostats market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#What Are the Current Market Growth and Trends in the Absorbable Hemostats Industry?#_x000D_

Leading businesses in the absorbable hemostats industry are striving to innovate advanced offerings such as absorbable hemostatic powder to ensure quick and efficient blood control in surgical procedures. This absorbable hemostatic powder is a medical innovation used to manage blood loss by inducing instantaneous clot formation at the damaged location, and the body naturally dissolves it after it has fulfilled its task. As an illustration, Baxter International Inc., a healthcare corporation based in the U.S., introduced its PERCLOT absorbable hemostatic powder in July 2023. The unique molecular structure of PERCLOT allows for rapid water absorption, leading to the creation of a gelled adhesive matrix that initiates a mechanical barrier to halt bleeding. This is achieved by the accumulation of platelets, red blood cells, and clotting proteins such as thrombin and fibrinogen. This capability greatly improves clinicians’ skillset in handling various degrees of intraoperative bleeding, playing an essential role in reducing blood transfusion needs, lowering significant complications, and eventually decreasing the total cost of treatment._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/absorbable-hemostats-global-market-report_x000D_

_x000D_

#What Are the Key Elements That Define the Absorbable Hemostats Market?#_x000D_

An absorbable hemostat is a medical device used to control bleeding during surgical procedures. It is designed to promote blood clotting and stabilize hemorrhaging tissues. An absorbable hemostat is made from materials that can be gradually broken down and absorbed by the body over time, eliminating the need for surgical removal._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18777_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 3156230293_x000D_

Asia +44 2071930708_x000D_

Europe +44 2071930708_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model